BD Set To Acquire Bard

Becton, Dickinson and Company (BD) and C. R. Bard, Inc. announce a definitive agreement under which BD will acquire Bard for $317.00 per Bard common share in cash and stock, for a total consideration of $24 billion. The agreement has been unanimously approved by the Boards of Directors of both companies.

 

The combination will create a highly differentiated medical technology company uniquely positioned to improve both the process of care and the treatment of disease for patients and healthcare providers. The transaction will build on BD's leadership position in medication management and infection prevention with an expanded offering of solutions across the care continuum. Additionally, Bard's strong product portfolio and innovation pipeline will increase BD's opportunities in fast-growing clinical areas, and the combination will enhance growth opportunities for the combined company in non-U.S. markets. 

Free Newsletter

Like this article? Subscribe to FierceSensors!

The sensors industry is constantly changing as innovation runs the market’s trends. FierceSensors subscribers rely on our suite of newsletters as their must-read source for the latest news, developments and analysis impacting their world. Register today to get sensors news and updates delivered right to your inbox.

 

For more info, visit http://www.bd.com

Suggested Articles

OmniVision's new OX01F10 SoC module provides automotive designers with a small form factor with low-light performance, ultra-low power and reduced cost.

Several industry leaders have formed a QSFP-DD800 Multi-Source Agreement (MSA) Group to expedite development of high-speed, double-density, quad small form…

NXP Semiconductors N.V. has announced its secure fine ranging chipset, SR100T, to achieve precise positioning performance for next-generation UWB-enabled…